As the Trump administration withdraws support for biotechnology innovation pushed by former president Biden, Europe is poised to seize the initiative

The U.S. administration of President Donald Trump has revoked Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” originally issued on September 12, 2022. This decision will have far-reaching consequences for the U.S. biotech industry.

The order was published and executed to advance engineering biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security.

President Trump’s U-turn on biotechnology could soon backfire. Republican senators from Nebraska, Indiana, Maine, Michigan, and Wyoming – states that have heavily invested in bioeconomy … will not be very amused about Trumps revocation. Brussels insiders had previously assumed that Trump would not harm those who voted him into office. The withdrawal of the executive order proves otherwise.

…

[Meanwhile,] France has built more than 20 biorefineries driven by the ambition to become a world leader in the bio-based economy, Italy will channel huge sums into the sector. At the end of February, the Italian parliament approved €2.2bn until 2027 for the conversion and construction of biorefineries that process classic bio-based residual streams.

This is an excerpt. Read the original post here